Stock Price
13.98
Daily Change
-0.07 -0.50%
Monthly
-10.90%
Yearly
26.86%
Q1 Forecast
15.11

Amarin reported $184.7M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
AbbVie USD 4.95B 13M Dec/2025
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
Amarin USD 184.7M 13.46M Sep/2025
AstraZeneca USD 6.59B 126M Sep/2025
BioCryst Pharmaceuticals USD 5.23M 188K Sep/2025
Esperion Therapeutics USD 108.54M 5.93M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Halozyme Therapeutics USD 176.48M 9.32M Dec/2025
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Neurocrine Biosciences USD 69M 300K Dec/2025
Novartis USD 6.42B 114M Sep/2025